HRP20040366B1 - Nova bakterijska bolest peradi - Google Patents

Nova bakterijska bolest peradi

Info

Publication number
HRP20040366B1
HRP20040366B1 HRP20040366AA HRP20040366A HRP20040366B1 HR P20040366 B1 HRP20040366 B1 HR P20040366B1 HR P20040366A A HRP20040366A A HR P20040366AA HR P20040366 A HRP20040366 A HR P20040366A HR P20040366 B1 HRP20040366 B1 HR P20040366B1
Authority
HR
Croatia
Prior art keywords
positive
negative
bacterium
beta
bacterial disease
Prior art date
Application number
HRP20040366AA
Other languages
English (en)
Croatian (hr)
Inventor
Elena Vazquez Maria
Campogarrido Raul
Gonzales-Hernandez Carlos
Sivanandan Vaithianathan
Original Assignee
Boehringer Ingelheim Vetmedica S.A. De C.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica S.A. De C.V. filed Critical Boehringer Ingelheim Vetmedica S.A. De C.V.
Publication of HRP20040366A2 publication Critical patent/HRP20040366A2/xx
Publication of HRP20040366B1 publication Critical patent/HRP20040366B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/295Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
HRP20040366AA 2001-10-26 2002-10-24 Nova bakterijska bolest peradi HRP20040366B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10152307A DE10152307A1 (de) 2001-10-26 2001-10-26 Neue bakterielle Geflügelkrankheit
PCT/EP2002/011899 WO2003037367A2 (en) 2001-10-26 2002-10-24 New bacterium causing poultry disease and vaccine derived thereof

Publications (2)

Publication Number Publication Date
HRP20040366A2 HRP20040366A2 (en) 2005-04-30
HRP20040366B1 true HRP20040366B1 (hr) 2012-05-31

Family

ID=7703460

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20040366AA HRP20040366B1 (hr) 2001-10-26 2002-10-24 Nova bakterijska bolest peradi

Country Status (31)

Country Link
US (3) US7794735B2 (de)
EP (2) EP1442114B1 (de)
JP (2) JP4447319B2 (de)
KR (2) KR100954175B1 (de)
CN (1) CN100471945C (de)
AR (3) AR037020A1 (de)
AT (1) ATE391767T1 (de)
AU (1) AU2002363173B2 (de)
BR (1) BR0213538A (de)
CA (1) CA2462652A1 (de)
CO (1) CO5580796A2 (de)
CY (1) CY1108178T1 (de)
DE (2) DE10152307A1 (de)
DK (1) DK1442114T3 (de)
EC (1) ECSP045083A (de)
ES (1) ES2304466T3 (de)
HR (1) HRP20040366B1 (de)
HU (1) HU228692B1 (de)
IL (1) IL161223A0 (de)
MA (1) MA26293A1 (de)
MX (1) MXPA04003941A (de)
MY (1) MY138203A (de)
NO (1) NO333635B1 (de)
NZ (1) NZ532805A (de)
PL (1) PL206589B1 (de)
PT (1) PT1442114E (de)
RU (4) RU2430967C2 (de)
SI (1) SI1442114T1 (de)
UA (2) UA89607C2 (de)
WO (1) WO2003037367A2 (de)
ZA (1) ZA200402499B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10152307A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit
CN102781954A (zh) * 2009-10-09 2012-11-14 哥本哈根大学 来自鸡卡氏杆菌的细胞溶解性rtx-毒素
CN102380092A (zh) * 2011-11-22 2012-03-21 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗
CN102406936A (zh) * 2011-11-22 2012-04-11 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗佐剂
HUE048344T2 (hu) 2013-03-18 2020-08-28 Intervet Int Bv Vakcina kérõdzõ védelmére Mannheimia haemolytica okozta tüdõgyulladás ellen
RU2563885C1 (ru) * 2014-06-03 2015-09-27 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Способ определения антител к бактериальным антигенам
CN104491856A (zh) * 2014-12-07 2015-04-08 青岛易邦生物工程有限公司 一种禽肺病毒病灭活疫苗的生产方法
CN108728558A (zh) * 2018-05-31 2018-11-02 广西壮族自治区兽医研究所 一种快速检测溶血性曼氏杆菌的pcr扩增引物及其应用
CN111621450B (zh) * 2020-07-10 2022-07-05 青岛易邦生物工程有限公司 一种鸭源鸡杆菌及其应用
CN120060520B (zh) * 2025-04-03 2026-02-03 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 一种检测海藻糖比伯斯坦杆菌的引物对和试剂盒

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0865791A1 (de) * 1997-03-17 1998-09-23 Vetoquinol S.A. Verwendung von Pasteurella haemolytica Serotyp A6 für die Herstellung eines Impfstoffes gegen Rinder-Pasteurellose verursacht durch Pasteurella haemolytica
US5849305A (en) * 1993-12-06 1998-12-15 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
US5855894A (en) * 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2051970C1 (ru) * 1992-06-24 1996-01-10 Северо-Кавказский зональный научно-исследовательский ветеринарный институт Способ выявления бактерий pasteurella multocida при пастереллезном процессе у птиц
US5576003A (en) * 1992-10-14 1996-11-19 Akzo Nobel N.V. Ornithobacterium rhinotracheale vaccine and method of immunization
RU2103355C1 (ru) * 1995-11-23 1998-01-27 Государственное Федеральное предприятие Государственный научный центр прикладной микробиологии Способ получения аттенуированных иммуногенных штаммов pasteurella multocida
CN1245058A (zh) * 1998-08-18 2000-02-23 曾泳铭 一种兽用抗病毒组合物
CA2394357C (en) * 1999-12-17 2014-04-22 University Of Guelph Modified leukotoxin gene and protein
US7521060B2 (en) * 2001-10-26 2009-04-21 Boehringer Ingelheim Vetmedica S.A. De C.V. Pathogen for bacterial poultry disease
DE10152307A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855894A (en) * 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
US5849305A (en) * 1993-12-06 1998-12-15 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
EP0865791A1 (de) * 1997-03-17 1998-09-23 Vetoquinol S.A. Verwendung von Pasteurella haemolytica Serotyp A6 für die Herstellung eines Impfstoffes gegen Rinder-Pasteurellose verursacht durch Pasteurella haemolytica

Also Published As

Publication number Publication date
BR0213538A (pt) 2004-10-19
UA96948C2 (ru) 2011-12-26
PL369963A1 (en) 2005-05-02
SI1442114T1 (sl) 2008-08-31
DE60226057T2 (de) 2009-05-14
NO20041675L (no) 2004-04-23
HK1073862A1 (zh) 2005-10-21
NO333635B1 (no) 2013-07-29
WO2003037367A2 (en) 2003-05-08
ES2304466T3 (es) 2008-10-16
ATE391767T1 (de) 2008-04-15
EP1942181A1 (de) 2008-07-09
HRP20040366A2 (en) 2005-04-30
DE60226057D1 (de) 2008-05-21
EP1442114B1 (de) 2008-04-09
HU228692B1 (en) 2013-05-28
KR20090083941A (ko) 2009-08-04
AU2002363173B2 (en) 2007-09-20
JP2010051324A (ja) 2010-03-11
UA89607C2 (ru) 2010-02-25
AR037020A1 (es) 2004-10-20
US20100104594A1 (en) 2010-04-29
RU2007129099A (ru) 2009-02-10
ZA200402499B (en) 2005-06-08
CO5580796A2 (es) 2005-11-30
IL161223A0 (en) 2004-09-27
JP5087604B2 (ja) 2012-12-05
CA2462652A1 (en) 2003-05-08
KR101024887B1 (ko) 2011-03-31
RU2334792C2 (ru) 2008-09-27
KR20050039688A (ko) 2005-04-29
NZ532805A (en) 2008-04-30
HUP0402098A3 (en) 2005-07-28
US20110212132A1 (en) 2011-09-01
WO2003037367A3 (en) 2003-10-09
CY1108178T1 (el) 2014-02-12
MXPA04003941A (es) 2004-11-29
AR067732A2 (es) 2009-10-21
ECSP045083A (es) 2004-08-27
HUP0402098A2 (hu) 2005-02-28
US7794735B2 (en) 2010-09-14
MA26293A1 (fr) 2004-09-01
PL206589B1 (pl) 2010-08-31
JP2005511032A (ja) 2005-04-28
AR073482A2 (es) 2010-11-10
PT1442114E (pt) 2008-05-20
US7964197B2 (en) 2011-06-21
MY138203A (en) 2009-05-29
RU2004116134A (ru) 2005-05-10
RU2008136404A (ru) 2010-03-20
KR100954175B1 (ko) 2010-04-20
JP4447319B2 (ja) 2010-04-07
EP1442114A2 (de) 2004-08-04
RU2430967C2 (ru) 2011-10-10
US20090181055A1 (en) 2009-07-16
RU2456343C2 (ru) 2012-07-20
CN100471945C (zh) 2009-03-25
RU2481393C2 (ru) 2013-05-10
DE10152307A1 (de) 2003-05-08
DK1442114T3 (da) 2008-06-09
RU2007148219A (ru) 2009-07-10
CN1575334A (zh) 2005-02-02

Similar Documents

Publication Publication Date Title
Brown et al. Evidence that mucoid Pseudomonas aeruginosa in the cystic fibrosis lung grows under iron-restricted conditions
ATE299712T1 (de) Stabilisatoren für lebendimpfstoffe
NO912603L (no) Polymer-blanding.
AR071888A2 (es) Bacteria pasteurellaceae gram-negativa, una composicion inmunogena, una composicion para vacunas
ES538984A0 (es) Procedimiento para la obtencion de un insecticida bacteriano
DE69726194D1 (de) Ds11 (kctc 02311bp), neuartiger bacillus sp. stamm und neue von diesem produzierte phytase
EP1076566A4 (de) Attenuierte salmonellamutanten, welche das vi-antigen konstant exprimieren
ATE295720T1 (de) Impfstoff für geflügel
AR067732A2 (es) Enfermedad bacteriana de las aves de corral
Jonas et al. Characterization of nine Pasteurella multocida isolates from avian cholera outbreaks in Indonesia
ES2146214T3 (es) Vacunas para actinobacillus pleuropneumoniae.
IT8120393A0 (it) Mutanti batterici, procedimento per produrli e vaccini vivi che licontengono.
ATE5075T1 (de) Derivate des waermebestaendigen enterotoxins von escherichia-coli und deren herstellung.
Pedersen et al. Interaction of the Chlamydia trachomatis histone H1‐like protein (Hc1) with DNA and RNA causes repression of transcription and translation in vitro
ES8302086A1 (es) Un procedimiento para preparar vacunas de pasteurella multocida y pasteunella haemolytica vivas modificadas con efectos veterinarios, particularmente para especies de animales bovinos, porcinos y ovinos.
FI864795A0 (fi) Komposition innehaollande primicin.
ES2072749T5 (es) Diagnostico de la hipertermia maligna porcina.
DK0963379T3 (da) Fructan med lav densitet og sammensætning indeholdende dette
ATE430800T1 (de) Neuartige glykosyltransferase-gene
ES463092A1 (es) Procedimiento de obtencion de los compuestos 8-(1h-tetrazol-5-il)-11h pirido (2,1-b) quinazolin-11-onas, y las sales farmaceuticamente aceptables de acidos y bases de los mis- mos.
IT8124990A0 (it) Sistema di controllo perfezionato dell'ugello di inserzione ad aria della trama.
Shulman MOVIE I PLAY REVIEW
Hughes et al. Gentamicin Resistance Plasmids in Hospital Infections.
RU98114307A (ru) Способ лечения бактериального вагиноза
ES8307828A1 (es) Procedimiento para la preparacion de tiazolo-y (1,3)tiazino-(2,3-c) (1,2,4) triazinonas con efecto herbicida selectivo.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20120926

Year of fee payment: 11

PBON Lapse due to non-payment of renewal fee

Effective date: 20131024